Chondroitin sulphate and glucosamine have a tropism for cartilaginous and joint tissues, which selectively bind to the degraded or injured cartilage, initiating the tissue regeneration process. The use of glycosaminoglycans helps to replace what was lost during pathological processes (cartilage repair) and what was lost in normal animal activity (cartilage protection). Another important property is its anti-inflammatory effect, noted after the use of these compounds. Glycosaminoglycans also inhibit the action of lysosomal enzymes (released by leukocytes into the synovial fluid) which induce production of hyaluronic acid and stimulate collagen synthesis. Other physiological effects of Chondroitin Sulfate: contribution to ossification and calcification of bones, as well as maintenance of elasticity of tendons and ligaments.

INDICATION

Indicated for dogs and cats to assist in the treatment of non-infectious arthropathy, such as: arthritis, arthrosis, osteoarthrosis, degenerative arthropathy, coxofemoral dysplasia, spondylosis, ankylosing spondylosis, chondropathies, synovitis, tendon diseases, osteodystrophy and chondrodystrophies, postoperative joint surgery, assisting in cases of fractures, as well as acting on the prophylaxis of osteoarticular diseases and cartilage protection in animals submitted to major exertion.

USES

• Arthropathy in general;
• Tendon diseases;
• Postoperative joint surgery;
• Assists in cases of fractures;
• Prevention of osteoarticular diseases;
• Cartilage protection for animals submitted to major exertion.

HOW TO USE

Used via injection, intramuscularly or subcutaneously.

EACH 100 mL  CONTAINS

PRESENTATION

Vial containing 10 mL.